Idox plc
('Idox' or the 'Group' or the 'Company')
Exercise of Share Options &
Total Voting Rights
Idox plc (AIM: IDOX) a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, announces that it has issued 76,852 new Ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by an employee under its Idox plc Long Term Incentive Plans.
Applications have been made for the 76,852 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 24 March 2022.
The total number of Ordinary Shares in issue following Admission will be 447,484,704. The Company holds 1,426,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 446,058,485.
The above figure of 446,058,485 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
-Ends-
Enquiries:
| Idox plc | +44 (0) 870 333 7101 | |
| Chris Stone, Non-Executive Chairman |
| |
| David Meaden, Chief Executive |
| |
| Anoop Kang, Chief Financial Officer |
| |
|
|
| |
| Peel Hunt LLP (NOMAD and Broker) | +44 (0) 20 7418 8900 | |
| Edward Knight |
| |
| Paul Gillam |
| |
| James Smith |
| |
|
|
| |
| MHP Communications | + 44 (0) 203 128 8100 | |
| Reg Hoare | idox@mhpc.com | |
| James Bavister |
| |
| Harry Clarke |
| |
|
|
| |
|
|
| |
About Idox plc
For more information see www.idoxplc.com @Idoxgroup
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
